Compare
Claritev Corp vs Payoneer Global Inc. vs Nutex Health Inc. vs Quinstreet, Inc
| Latest fiscal year | Claritev Corp CTEV | Payoneer Global Inc. PAYO | Nutex Health Inc. NUTX | Quinstreet, Inc QNST |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-06-30 |
| Revenue | $965.41M | $1.05B | $875.26M | $1.29B |
| Revenue growth (YoY) | +3.7% | +7.7% | +82.4% | +18.3% |
| Gross margin | n/a | n/a | 50.8% | 11.3% |
| Operating margin | 3.0% | 11.8% | 31.5% | 2.7% |
| Net margin | -29.4% | 7.0% | 8.1% | 6.3% |
| Net income | -$284.28M | $73.19M | $70.79M | $81.23M |
| EPS (Diluted) | -$17.30 | $0.19 | $10.48 | $1.40 |
| Operating cash flow | $117.32M | $233.49M | $248.12M | $131.30M |
| Free cash flow | -$12.28M | $206.62M | $245.60M | $127.91M |
| Cash & equivalents | $16.81M | $415.54M | $185.57M | $128.31M |
| Total assets | $4.89B | $8.96B | $918.52M | $721.30M |
| Total liabilities | $5.06B | $8.25B | $495.09M | $398.21M |
| Shareholders' equity | -$173.90M | $704.43M | $423.44M | $323.09M |
| Return on year-end equity | n/a | 10.4% | 16.7% | 25.1% |
| Shares outstanding | 16.55M | 348.70M | 7.09M | 56.49M |
Revenue, most recent five fiscal years
| Fiscal year | Claritev Corp | Payoneer Global Inc. | Nutex Health Inc. | Quinstreet, Inc |
|---|---|---|---|---|
| Latest | $965.41M Ended 2025-12-31 | $1.05B Ended 2025-12-31 | $875.26M Ended 2025-12-31 | $1.29B Ended 2026-06-30 |
| 1 year earlier | $930.62M Ended 2024-12-31 | $977.72M Ended 2024-12-31 | $479.95M Ended 2024-12-31 | $1.09B Ended 2025-06-30 |
| 2 years earlier | $961.52M Ended 2023-12-31 | $831.10M Ended 2023-12-31 | $247.65M Ended 2023-12-31 | $613.51M Ended 2024-06-30 |
| 3 years earlier | $1.08B Ended 2022-12-31 | $627.62M Ended 2022-12-31 | $219.29M Ended 2022-12-31 | $580.62M Ended 2023-06-30 |
| 4 years earlier | $1.12B Ended 2021-12-31 | $473.40M Ended 2021-12-31 | $331.53M Ended 2021-12-31 | $582.10M Ended 2022-06-30 |